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FACSVisceral leishmaniasis is a vector-borne disease caused by an obligate intracellular protozoan parasite Leishmania
donovani. The molecular mechanism involved in internalization of Leishmania is poorly understood. The entry of
Leishmania involves interaction with the plasma membrane of host cells. We have previously demonstrated the
requirement of host membrane cholesterol in the binding and internalization of L. donovani intomacrophages. In
the present work, we explored the role of the host actin cytoskeleton in leishmanial infection. We observed a
dose-dependent reduction in the attachment of Leishmania promastigotes to host macrophages upon destabili-
zation of the actin cytoskeleton by cytochalasin D. This is accompanied by a concomitant reduction in the intra-
cellular amastigote load. We utilized a recently developed high resolution microscopy-based method to
quantitate cellular F-actin content upon treatment with cytochalasin D. A striking feature of our results is that
binding of Leishmania promastigotes and intracellular amastigote load show close correlation with cellular F-
actin level. Importantly, the binding of Escherichia coli remained invariant upon actin destabilization of host
cells, thereby implying speciﬁc involvement of the actin cytoskeleton in Leishmania infection. To the best of
our knowledge, these novel results constitute the ﬁrst comprehensive demonstration on the speciﬁc role of the
host actin cytoskeleton in Leishmania infection. Our results could be signiﬁcant in developing future therapeutic
strategies to tackle leishmaniasis.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Leishmaniasis is a vector-borne disease, caused by various species of
the genus Leishmania, which are obligate intracellular protozoan para-
sites. Leishmaniasis causes substantial public health problems, especial-
ly in tropics, subtropics and theMediterranean basin, and is usually fatal
if left untreated [1–4]. Leishmaniasis threatens about 350 million men,
women and children in 98 countries around the world. As many as 12
million people are believed to be currently infected,with about 1–2mil-
lion estimated new cases occurring every year [5,6]. In socioeconomic
terms, leishmaniasis is often associated with poverty [7] and is believed
to be oneof themost neglected diseases due to limited funding available
for diagnosis, treatment and control [8]. According to available
estimates, leishmaniasis is considered to be second in mortality and
fourth in morbidity among all tropical diseases [9]. Based on clinicaloxide; FCS, fetal calf serum; FITC,
2-yl)-2,5-diphenyl-tetrazolium
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it@ccmb.res.insyndromes, leishmaniasis is classiﬁed into four major types: cutaneous,
muco-cutaneous, visceral (also known as kala-azar) and post-kala-azar
dermal leishmaniasis. Among these, visceral leishmaniasis (VL) is
fatal in the absence of treatment [3]. The current worldwide increase
in leishmaniasis to epidemic proportions, and the emergence of VL
as an important opportunistic infection among people infected with
HIV-1 [10] have given rise to an urgency to provide treatment for
leishmaniasis.
Leishmaniasis is transmitted by the bite of the infected female
sandﬂy (Phlebotomus spp.) while taking a bloodmeal from a host [11].
The lifecycle of Leishmania has two distinct forms: an extracellular
promastigote ﬂagellar form found in the mid-gut of sandﬂies, and an
intracellular amastigote form that resides in phagolysosomes of host
macrophages. After entering the bloodstream, promastigotes are inter-
nalized by dendritic cells and macrophages, and subsequently trans-
form into amastigotes by losing their ﬂagella [3,12]. The entry of
promastigotes into host macrophages involves multiple host–parasite
interactions such as recognition of speciﬁc ligands on the parasite cell
surface by receptors on the macrophage cell surface [4]. Studies aimed
at understanding the molecular mechanisms of entry of Leishmania
into host cells have led to the identiﬁcation of a number of candidate re-
ceptors facilitatingmultiple routes of entry, thereby highlighting the re-
dundancy in the entry process [2,13,14]. These include membrane
2012 S. Roy et al. / Biochimica et Biophysica Acta 1838 (2014) 2011–2018receptors on the host macrophage cell surface such as the mannose-
fucose receptor, receptor for advanced glycosylation end products, the
ﬁbronectin receptor, the Fc receptor and complement receptors such
as CR1 andCR3. Due to the large variety of receptors responsible for par-
asite entry into host macrophages, no panacea is available for the treat-
ment of leishmaniasis.
The entry of intracellular parasites such as Leishmania involves inter-
action of the parasite with the plasma membrane of host cells. In this
context, we were the ﬁrst to demonstrate the requirement of host
membrane cholesterol in the binding and internalization of Leishmania
donovani into macrophages using complementary approaches [12,
15–20]. Membrane cholesterol has also been shown to be necessary
for the entry of Leishmania chagasi into hostmacrophages [21]. Interest-
ingly, depletion of plasma membrane cholesterol has recently been re-
ported to result in possible reorganization of the cortical actin
cytoskeleton [22–27].With the overall goal of delineating plasmamem-
brane components of host macrophages responsible for the entry of
Leishmania and arrive at a comprehensivemolecularmechanism of par-
asite entry, in this work, we have explored the role of the actin cytoskel-
eton in parasite entry. Our results show that destabilization of the actin
cytoskeleton of host macrophages results in a dose-dependent reduc-
tion in the attachment of Leishmania promastigotes, along with a con-
comitant reduction in the intracellular amastigote load. Importantly,
we demonstrate here that Leishmania infection is strongly correlated
with cellular F-actin level. To the best of our knowledge, these novel re-
sults constitute the ﬁrst comprehensive demonstration on the speciﬁc
role of the host actin cytoskeleton in Leishmania infection.A
C
Fig. 1. Organization of the actin cytoskeleton in J774A.1 macrophages treated with increasing c
546 phalloidin. Projections of 11 sections from the base of the coverslip (~3.5 μm from the bas
rophages, and panels B–D show corresponding images formacrophages treatedwith 2.5, 5 and
observed upon treatment with increasing concentrations of CD. The scale bar represents 10 μm2. Materials and methods
2.1. Materials
MgCl2, CaCl2, cytochalasin D (CD), antibiotic antimycotic solution,
gentamicin sulfate, IMDM (Iscove’s Modiﬁed Dulbecco’s Medium), M-
199 (Medium-199), MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide), FITC (Fluorescein isothiocyanate) and Giemsa
stain were obtained from Sigma (St. Louis, MO). Fetal calf serum (FCS)
was purchased from Gibco/Life Technologies (Grand Island, NY), PE
(phycoerythrin) rat anti-mouse CD14 antibody was obtained from BD
Biosciences (Franklin Lakes, NJ) and Alexa Fluor 546 phalloidin was
obtained from Molecular Probes/Invitrogen (Eugene, OR). All other
chemicals used were of the highest available purity. Water was puriﬁed
through aMillipore (Bedford,MA)Milli-Q system and used throughout.2.2. Methods
2.2.1. Cell culture
Murinemacrophage cell line J774A.1 (American TypeCulture Collec-
tion) was maintained as described previously [15,28] with some modi-
ﬁcations. Cells were maintained in IMDMmedium supplemented with
2.4 g/l sodium bicarbonate, 10% heat-inactivated FCS, and antibiotic
antimycotic (100 U/ml penicillin, 100 μg/ml streptomycin, and
0.25 μg/ml amphotericin B) solution in a humidiﬁed atmosphere with
5% CO2 at 37 °C.B
D
oncentrations of cytochalasin D (CD). The actin cytoskeleton was stained with Alexa Fluor
e into the cell) are shown. Panel A shows representative projected image for control mac-
10 μMCD, respectively. Loss of F-actinﬁlaments and formation of F-actin aggregates can be
. See Materials and methods for other details.
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Leishmania donovani strain AG83 (MHOM/IN/1983/AG83)
promastigotes were maintained as described previously
[29]. Promastigotes were maintained in M-199 medium,100
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Fig. 2. Effect of destabilization of the actin cytoskeleton of J774A.1 macrophages on binding of
destabilized using increasing concentrations of CD. Promastigotes were added onto macrophag
tative confocal microscopic images of promastigotes bound to untreated (control) and CD-trea
labeled with FITC (green) and CD14 (macrophage surface marker) was labeled with PE rat ant
estimates of FITC-labeled promastigotes bound to untreated (control) and CD-treatedmacropha
with untreated (control) macrophages. Data represent means ± S.E. of duplicate points from f
ﬂuorescence associated with macrophages treated with CD relative to control macrophages). Ssupplemented with 200 μg/ml gentamicin sulfate and 10% heat-
inactivated FCS at 22 °C. To ensure that only virulent
promastigotes were used, we routinely checked their capacity to
infect hamsters.5 10
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FITC-labeled Leishmania donovani promastigotes. Actin cytoskeleton of macrophages was
es at a multiplicity of infection of 10:1 (parasite to macrophage). Panel A shows represen-
ted macrophages. Macrophage nucleus was stained with DAPI (blue), promastigotes were
i-mouse CD14 antibody (red). The scale bar represents 10 μm. Panel B shows quantitative
ges, asmonitored by ﬂow cytometry. Values are normalized to theﬂuorescence associated
our independent experiments (* corresponds to signiﬁcant (p b 0.05) difference in mean
ee Materials and methods for other details.
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Fig. 3. Iso-surface generation and quantitation of F-actin in J774A.1 macrophages. Iso-
surfaces of the sections corresponding to projections shown in Fig. 1 were generated
using the iso-surface tool in Imaris. In order to quantitate F-actin, the volume enclosed
by the iso-surface was normalized to the projected area of cells obtained using the soft-
ware provided with LSM 510 Meta confocal microscope. Panel A shows iso-surface for
control macrophages, and panels B–D show iso-surfaces corresponding to macrophages
treated with 2.5, 5 and 10 μM CD, respectively. Values obtained upon quantitation of F-
actin in control and CD-treated cells are shown in panel E. Data represent means ± S.E.
of at least 11 independent measurements (*** corresponds to signiﬁcant (p b 0.001) dif-
ference in F-actin content in macrophages treated with CD relative to control macro-
phages). The inset shows correlation of binding of L. donovani promastigote and F-actin
content of macrophages with increasing concentrations of CD. Data plotted are taken
from Figs. 2 and 3E. Linear regression analysis yielded a correlation coefﬁcient (r) ~0.96.
The signiﬁcance of the correlation is apparent from the 95% conﬁdence band (plotted as
dashed lines). See Materials and methods for other details.
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Destabilization of macrophage actin cytoskeleton was carried out
using CD as described earlier [30,31] with some modiﬁcations. Brieﬂy,
a stock solution of 2mMCDwasprepared in DMSO, and further concen-
trations for treatments were prepared upon dilution of the stock in
serum-free IMDM medium. J774A.1 macrophages were grown for
48 h followed by incubation in IMDM medium without serum and
antibiotic antimycotic supplements for 3 h. Actin cytoskeleton was
destabilized by treating macrophages with increasing concentrations
of CD in serum-free IMDM medium for 30 min at 37 °C. Following the
treatment, medium containing CD was removed and macrophages
were washed twice with PBS (in order to remove excess CD) before
infecting with Leishmania promastigotes. The amount of DMSO was
always b0.5% (v/v). Treatment of control cells with similar amounts of
DMSO did not show any change in cellular morphology.
2.2.4. MTT viability assay
MTT assay was carried out as described earlier [32,33] to assess the
viability of J774A.1 macrophages treated with CD. Macrophages in the
mid log phase were plated at a density of ~1 × 104 in 96-well plates
and treatments were carried out as described in Section 2.2.3. MTT
was dissolved in serum-free IMDMmedium and added tomacrophages
at a ﬁnal concentration of 0.5 mg/ml, followed by incubation at 37 °C for
3 h. Formazan crystals formed upon reduction of MTT salt bymitochon-
drial enzymes in live cells [32] are insoluble in aqueous medium. Cells
were centrifuged in 96-well plates and the formazan crystals formed
were subsequently dissolved in DMSO after discarding the medium.
The color obtained was measured by absorbance at 492 nm in a
Multiskan Ex microplate reader (Thermo Scientiﬁc, Hudson, NH).
2.2.5. F-actin labeling of macrophages
Actin labeling in J774A.1 macrophages was carried out as described
previously [31]. Brieﬂy, macrophages were plated at a density of
~1 × 104 on glass coverslips and grown in IMDM medium for 48 h
followed by incubation in serum-free IMDMmedium for 3 h and subse-
quent treatment with CD. Macrophages were then washed with buffer
A (PBS containing 1 mM CaCl2 and 0.5 mM MgCl2), and ﬁxed with
3.5% (v/v) formaldehyde for 10 min. Permeabilization of cells was car-
ried out in buffer A with 0.5% Triton X-100 (v/v) for 6 min. Cells were
washed, stained with Alexa Fluor 546 phalloidin for 1 h, and mounted.
2.2.6. Fluorescence microscopy and F-actin quantitation
All images were acquired on an inverted Zeiss LSM 510Meta confo-
cal microscope (Jena, Germany). F-actin was imaged by exciting Alexa
Fluor 546 phalloidin at 561 nm and collecting emission from 575 to
630 nm. F-actin quantitation was carried out using a technique recently
developed by us [31]. Brieﬂy, images of z-sections were acquired with a
63×/1.4 NA oil immersion objective under 1 airy condition, with a ﬁxed
step size of 0.32 μm. Projections of 11 sections (~3.5 μm from the base
into the cell) were generated, and area of the projected images was de-
termined manually using the software provided with Zeiss LSM 510
Meta confocal microscope. Iso-surfaces (deﬁned as contours made
upon joining voxels of equal ﬂuorescence intensity) were generated
from z-sections corresponding to each projected image using Imaris
6.0.0 software (Bitplane AG, Zurich, Switzerland). Iso-surfaces were ob-
tained upon ﬂuorescence intensity thresholding of z-sections followed
by applying a Gaussian ﬁlter. The estimated volumes enclosed by iso-
surfaces were normalized to the projected area of cells for a given ﬁeld.
2.2.7. FITC labeling and binding analysis of L. donovani promastigotes
L. donovani promastigoteswere labeledwith FITC as described previ-
ously [15,34] with some modiﬁcations. Brieﬂy, parasites grown to mid
log phase were washed with PBS and labeled with 0.1% FITC in buffer
B (50 mM carbonate buffer, pH 8.0) for 1 h at 22 °C. Parasites were ex-
tensively washed in PBS and suspended in IMDMmedium supplement-
ed with 2% heat-inactivated FCS for further experiments. Uniformlabeling of promastigotes with FITC was conﬁrmed using ﬂow cytome-
try. Macrophages treated with CD were washed twice with PBS to re-
move excess CD. FITC-labeled promastigotes were added onto
macrophages at a multiplicity of infection of 10:1 (parasite to macro-
phage) and incubated for 4 h at 37 °C. Subsequently, macrophages
were collected, washed and suspended in PBS. The ﬂuorescence from
FITC-labeled parasites associated with 10,000 macrophages was moni-
tored using FACS Calibur ﬂow cytometer (BD Biosciences, San Jose,
CA) and analyzed using the in-built CellQuest Pro analysis software.
2015S. Roy et al. / Biochimica et Biophysica Acta 1838 (2014) 2011–20182.2.8. Microscopic analysis of intracellular amastigote counts
Microscopic analysis of infected macrophages was carried out as
described earlier [15,19] with some modiﬁcations. L. donovani
promastigotes were added onto macrophage monolayers grown onControl 2.5
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Fig. 4. Effect of destabilization of the actin cytoskeleton of J774A.1 macrophages on binding of F
concentrations of CD, at a ratio of 100:1 (bacteria to macrophage). Panel A shows representativ
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Fig. 5. Effect of destabilization of the actin cytoskeleton on internalization of the parasite
assessed by amastigote count in infected J774A.1 macrophages. Macrophages treated
with CD were exposed to parasites at a multiplicity of infection of 10:1 (parasite to
macrophage) for 24 h. The number of intracellular amastigotes in macrophages
was counted subsequent to Giemsa staining. Data represent means ± S.E. of duplicate
points from three independent experiments (* and ** correspond to signiﬁcant (p b 0.05
and p b 0.01) difference in amastigote count in macrophages treated with CD relative to
control macrophages). See Materials and methods for other details.
2016 S. Roy et al. / Biochimica et Biophysica Acta 1838 (2014) 2011–2018macrophages was visually scored using a Zeiss microscope with a 100×
oil objective, and the amastigote count was normalized to 100
macrophages.
2.2.9. FITC labeling and binding analysis of E. coli
E. coliDH5α cells were labeledwith FITC as described previously [15,
34] with some modiﬁcations. Brieﬂy, E. coli was grown overnight in
Luria broth at 37 °C under shaking. Bacteria were labeled with 0.1%
FITC in buffer B for 30 min at 37 °C while being shaken. Cells were
pelleted down and washed extensively with PBS to remove unbound
stain. FITC-labeled bacteria were added onto macrophages at a multi-
plicity of 100:1 (bacteria to macrophage) and incubated for 30 min at
37 °C. Cells were processed and analyzed using ﬂow cytometry as de-
scribed in Section 2.2.7.
2.2.10. Fluorescence imaging of L. donovani and E. coli binding to
macrophages
Macrophages were plated at a density of 2 × 104 on glass coverslips
and grown in IMDMmedium for 48 h. Macrophages were then treated
with CD and subsequently infected with FITC-labeled L. donovani
promastigotes or E. coli, as described in Sections 2.2.7 and 2.2.9, respec-
tively. Cells were washed with PBS to remove unbound promastigotes
(or bacteria) and the CD14 macrophage surface marker was labeled
with PE rat anti-mouse CD14 antibody for 30 min at 4 °C. Cells were
washed, ﬁxed with 3.5% (v/v) formaldehyde and mounted in media
containing DAPI. Images were acquired on an Andor Spinning Disc Con-
focal microscope (Belfast, U.K.) with a 60×/1.42 NA oil immersion
objective.
2.2.11. Statistical analysis
Signiﬁcance levels were estimated using Student’s two-tailed un-
paired t-test using Graphpad Prism software version 4.0 (San Diego,
CA). The correlation between promastigote binding and F-actin content
of macrophages treated with increasing concentrations of CD was ana-
lyzed using the same software with 95% conﬁdence interval. Plots
were generated using Microcal Origin software, version 6.0 (OriginLab,
Northampton, MA).
3. Results
3.1. Actin organization in host macrophages is altered upon treatment with
cytochalasin D
Actin is one of the most abundant cytosolic proteins in eukaryotic
cells and exists in both monomeric (globular or G-actin) and polymeric
(ﬁlamentous or F-actin) forms. F-actin is maintained in cells in dynamic
equilibrium with soluble G-actin. Cytochalasins act as potent inhibitors
of actin polymerization. Earlier in vitro studies have indicated that CD
severs polymerized actin by predominantly binding to the barbed
(fast growing) end of the actinﬁlament thereby shifting the equilibrium
toward depolymerization [35]. However, the mechanism of action
in vivo appears to be a combination of the above effect of the drug and
a secondary cellular response, leading to intensive disruption of the
actin cytoskeletal network [36]. In order to monitor the role of the
actin cytoskeletal network on the extent of leishmanial infection, we
treated host murine macrophage cell line J774A.1 with CD. Fig. 1
shows the effect of increasing concentrations of CD on the organization
of the actin cytoskeleton in host macrophages. The ﬁgure shows confo-
cal images of the actin cytoskeleton (stained with Alexa Fluor 546
phalloidin) of host macrophages treated with CD. Treatment of host
macrophages with CD resulted in fragmentation of F-actin, and the con-
sequent loss of F-actin ﬁlaments and formation of F-actin aggregates can
be observed under these conditions (see Fig. 1). We found the action of
CD onmacrophages to be fast, and changes in cellularmorphologywere
visible withinminutes of treatment for higher concentrations of CD.We
chose to use an optimal concentration range of CD in these experimentsso that the cellular morphology would remain more or less intact. We
also optimized the period of treatment such that cellular morphology
is retained over the time of measurement for the maximal concentra-
tion of CD used. In order to assess the effect of CD on cell viability,
J774A.1 cells were tested for viability using MTT viability assay follow-
ing CD treatment. MTT assay is a cell proliferation assay and provides
an estimate of the cell growth rate and viability of the cells. No apprecia-
ble cell death was observed over the range of concentrations of CD used
(see Fig. S1).3.2. Actin destabilization in host macrophages reduces binding of Leish-
mania promastigotes
We assessed the role of the actin cytoskeleton on the extent of leish-
manial infection by studying (a) parasite interaction with the host cell
surface by monitoring the binding of ﬂuorescently (FITC)-labeled
promastigotes, the extracellular form of the parasite, by ﬂow cytometric
analysis and confocal microscopy; and (b) the eventual presence of the
intracellular amastigote form of the parasite inside host macrophages.
Fluorescent derivatization of promastigotes with FITC is a convenient
method to accurately monitor host-parasite interaction at the cell sur-
face, since each cell is analyzed individually for its ability to bind FITC-
labeled promastigotes [15,34,37]. Fig. 2A shows ﬂuorescence microsco-
py images of Leishmania donovani promastigotes bound tomacrophages
upon destabilization of the host actin cytoskeleton. The ﬁgure shows re-
duction in promastigotes bound tomacrophages upon actin destabiliza-
tion. We quantitated the reduction in promastigote binding upon actin
destabilization using ﬂow cytometry (shown in Fig. 2B). Fig. 2B shows
a dose-dependent reduction in the binding of promastigotes (normal-
ized to control cells) to host macrophages upon treatmentwith increas-
ing concentrations of CD. We observed a modest (~12%) reduction in
promastigote binding upon mild actin destabilization (2.5 μM CD).
With increasing actin destabilization using higher concentrations of
CD, we observed progressive reduction in promastigote binding. For ex-
ample, promastigote bindingwas reduced by ~33%when 10 μMCDwas
used (see Fig. 2B). These results show that actin destabilization affects
the ability of Leishmania promastigotes to interact with the host macro-
phage cell surface.
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with cytochalasin D
In order to analyze the reduction in parasite binding in terms of actin
reorganization, it is important to quantitatively estimate the extent of
actin destabilization under these conditions. Unfortunately, intensity-
based analysis is not suitable for quantitation of actin reorganization.
This is because treatment with CD results in fragmentation of actin ﬁla-
ments into smaller F-actin aggregates, which appear brighter under a
ﬂuorescencemicroscope. In order to overcome this problem, we recent-
ly developed a high resolution microscopy-based approach to quantita-
tively assess the changes in actin organization. This method allows
quantitation of F-actin by high magniﬁcation imaging followed by
image reconstruction [31]. Fig. 3 (panels A–D) shows iso-surface images
corresponding to projected images shown in Fig. 1. In order to quantita-
tively estimate F-actin, the volumes enclosed by the iso-surfaces were
normalized in each case to the projected area of cells. The F-actin con-
tent upon CD treatment quantitated this way is shown in Fig. 3E. As
can be seen from the ﬁgure, CD treatment resulted in a dose-
dependent reduction in cellular F-actin level.
3.4. Reduction in promastigote binding to host macrophages strongly corre-
lates with cellular F-actin content
In order to examine a possible correlation between the reduction in
cellular F-actin level and the corresponding decrease in promastigote
binding to host macrophages, we plotted F-actin levels (from Fig. 3E)
vs. parasite attachment to host cells (from Fig. 2B). This plot is shown
as an inset in Fig. 3E. A linear regression analysis between F-actin level
and promastigote binding produced a positive correlation of ~0.96.
The 95% conﬁdence intervals contained all the data points, implying a
signiﬁcant relationship between the two parameters observed. Such a
tight correlation between F-actin level and parasite binding implies a
distinct molecular basis of promastigote binding with cellular actin.
3.5. Actin destabilization of host macrophages does not affect the binding of
E. coli
To evaluate the speciﬁc role of the host actin cytoskeleton in
Leishmania infection, as a control, we monitored the effect of actin
destabilization of host macrophages on the binding of E. coli DH5α.
Fig. 4A showsﬂuorescencemicroscopy images of E. coli bound tomacro-
phages upon destabilization of the host actin cytoskeleton.We observed
that the binding of E. coli remains invariant over the range of CD concen-
trations used, i.e., is independent of cellular F-actin level. This observa-
tion was further conﬁrmed by quantifying the number of E. coli bound
to macrophages using ﬂow cytometry (shown in Fig. 4B). These results
are in sharp contrast to the dose-dependent reduction in promastigote
binding (shown in Fig. 2B) upon progressive actin destabilization
(Fig. 3E). These results therefore point to the speciﬁcity of actin-
dependent interaction between Leishmania promastigotes and themac-
rophage cell surface.
3.6. Reduction in promastigote binding is associated with loss of intracellu-
lar load of amastigotes
The above results demonstrate that actin destabilization leads to a
reduction in the ability of promastigotes to interact with and bind to
host macrophages. For efﬁcient infection to take place, binding of the
parasite should be followed by internalization and survival. The reduced
binding of thepromastigotes should thereforemanifest as a reduction in
the number of amastigotes, the intracellular form of the parasite. The
number of amastigotes was scored visually after staining the infected
macrophages with Giemsa. Fig. 5 shows that treatment of macrophages
with increasing concentrations of CD resulted in a concomitant reduc-
tion in the number of amastigotes present (relative to control cells) inthe macrophages. The reduction in amastigote count was ~27% when
2.5 μM CD was used (see Fig. 5). With increasing concentrations of CD,
further reduction in amastigote loadwas observed,with ~47% reduction
in amastigote count upon treatment with 10 μMCD. These results com-
prehensively demonstrate that actin destabilization affects the intracel-
lular load of amastigotes. A linear regression analysis between F-actin
level and intracellular amastigote load gave a positive correlation of
~0.99 (data not shown).4. Discussion
The actin cytoskeleton is involved in a variety of cellular responses
besides providing structural support. The extent of actin polymerization
and depolymerization is orchestrated by a number of actin binding pro-
teins in response to diverse stimuli [38]. This offers a mechanism such
that dynamic changes in the actin cytoskeleton act as a transducer in
communicating signaling transients. While the role of the actin cyto-
skeleton in cellular processes such as trafﬁcking and motility has been
extensively studied [39], the role of the actin cytoskeleton in the entry
of intracellular pathogens has been addressed only rarely.
A number of studies have indicated the crucial requirement ofmem-
brane cholesterol in host-pathogen interaction (recently reviewed in
[12]). In this overall scenario, we previously demonstrated the require-
ment of membrane cholesterol in Leishmania donovani infection [15,16,
19]. Several studies have suggested a possible relationship between
membrane domains and the actin cytoskeleton [24]. As mentioned
above, depletion of plasma membrane cholesterol has earlier been re-
ported to result in possible reorganization of the cortical actin cytoskel-
eton [22–27]. For example, it has been reported that depletion of plasma
membrane cholesterol could induce changes in the underlying actin cy-
toskeleton by loss or redistribution of phosphatidylinositol 4,5-
bisphosphate [PI(4,5)P2] molecules in the membrane [22]. In addition,
membrane cholesterol depletion has been reported to cause inhibition
of neutrophil motility and reduction in actin-dependent protrusions in
human neutrophils in response to chemoattractants [40]. With this
background, our present results showing reduction in leishmanial infec-
tion upon actin reorganization assume signiﬁcance. Although there
have been some earlier reports suggesting a possible role of the actin cy-
toskeleton in the entry of Leishmania species into host cells [41–44], our
results represent the ﬁrst comprehensive demonstration on the speciﬁc
role of the host actin cytoskeleton in Leishmania infection. More impor-
tantly, we show here that the host F-actin level and parasite binding are
strongly correlated (shown as inset in Fig. 3E). Interestingly, it has been
speculated that cytoskeletal reorganization is a requisite for pathogen
entry into host cells [45]. To this end, we utilized the above mentioned
high resolution imaging approach to quantitate possible changes in
host F-actin content upon infection. Our results show that L. donovani
infection itself does not result in a signiﬁcant change in F-actin content
of hostmacrophages (see Fig. S2). These observations allow speculation
about possible mechanism underlying the interaction of the intracellu-
lar pathogen with the host cell surface.
A number of membrane receptors have been recognized as possible
targets for facilitating the entry of Leishmania into host cells [2,13,14],
andmetabolic pathways required by the parasite for its survival and vir-
ulence have been identiﬁed [46]. Cellular signaling and dynamics of
membrane receptors have been reported to be regulated by the actin
cytoskeleton [27,30,47]. In addition, activation of membrane receptors
(particularly, G protein-coupled receptors) induces reorganization of
the actin cytoskeleton [31]. A number of studies have shown that mem-
brane domains (sometimes termed ‘lipid rafts’) are implicated in the
entry of pathogens into host cells [45,48,49]. Several key molecules in-
volved in tethering membrane domains to the actin cytoskeleton have
been identiﬁed [50]. In addition, a feedback mechanism has been pro-
posed between membrane domains and the actin cytoskeleton during
cell migration and activation [51]. In this overall context, our present
2018 S. Roy et al. / Biochimica et Biophysica Acta 1838 (2014) 2011–2018results on the novel role of the actin cytoskeleton in leishmanial infec-
tion in host macrophages assume relevance.
Taken together, our present results show actin as amajor cell surface
component (besides cholesterol) responsible for parasite entry into
host cells. A close correlation between F-actin level and parasite binding
and amastigote load reinforces the molecular signiﬁcance of the role of
the actin cytoskeleton in leishmanial infection. We envision that these
results could be signiﬁcant in developing future therapeutic strategies
to tackle leishmaniasis in particular, and diseases caused by other intra-
cellular pathogens in general.
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